Landscape and clinicopathologic features of RAS pathway mutations in chronic myelomonocytic leukemia.

Blood Adv · 2025 · PMC12848361 · PMID 40644618

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Among patients with CMML with KIT mutations, those with SM had numerically higher median VAF of KIT D816 mutations compared with those without SM (27% vs 15%; P = .3603), but differences did not reach statistical significance ( supplemental Figure 7 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.